DOD Biotech Public Company Limited - Depositary Receipt (Common Stock) - Laporan Laba Rugi (TTM)

DOD Biotech Public Company Limited - Depositary Receipt (Common Stock)
TH ˙ SET
Laporan Laba Rugi (TTM)

Laporan Laba Rugi DOD Biotech Public Company Limited - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,024 1,080 1,254 1,276 1,171 1,018 824 713 696 548 509 562 588 693 741 707 691 662 665 662
Change (%) 5.44 16.15 1.74 -8.25 -13.03 -19.10 -13.51 -2.33 -21.20 -7.09 10.28 4.75 17.71 6.93 -4.53 -2.25 -4.23 0.41 -0.39
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 572 616 714 711 654 581 504 454 461 397 368 383 373 406 433 449 445 439 442 417
Change (%) 7.82 15.83 -0.43 -7.96 -11.25 -13.26 -9.77 1.40 -13.93 -7.31 4.24 -2.73 9.01 6.46 3.73 -0.86 -1.42 0.78 -5.70
% of Revenue 55.82 57.08 56.92 55.71 55.88 57.02 61.14 63.79 66.23 72.34 72.17 68.22 63.35 58.66 58.40 63.45 64.36 66.25 66.49 62.95
Gross Operating Profit 453 464 540 565 517 438 320 258 235 152 142 179 216 286 308 258 246 223 223 245
Change (%) 2.43 16.58 4.60 -8.61 -15.28 -26.86 -19.40 -8.91 -35.47 -6.53 25.94 20.81 32.76 7.60 -16.12 -4.68 -9.30 -0.32 10.16
% of Revenue 44.18 42.92 43.08 44.29 44.12 42.98 38.86 36.21 33.77 27.66 27.83 31.78 36.65 41.34 41.60 36.55 35.64 33.75 33.51 37.05
SG&A 238 107 108 107 112 128 144 158 164 163 174 168 185 199 204 220 214 209 193 187
Change (%) -55.15 1.00 -0.45 4.59 14.39 12.33 9.45 3.86 -0.51 6.59 -3.17 9.94 7.30 2.80 7.92 -3.00 -2.17 -7.51 -3.16
% of Revenue 23.23 9.88 8.59 8.41 9.58 12.60 17.50 22.15 23.55 29.74 34.11 29.95 31.44 28.66 27.55 31.14 30.91 31.57 29.08 28.27
R&D
Change (%)
% of Revenue
OpEx 810 723 822 818 767 709 649 613 625 560 540 551 558 605 637 669 659 648 635 604
Change (%) -10.68 13.64 -0.43 -6.31 -7.50 -8.49 -5.50 1.92 -10.44 -3.44 1.88 1.26 8.49 5.26 5.07 -1.56 -1.66 -1.89 -4.93
% of Revenue 79.05 66.96 65.51 64.11 65.47 69.63 78.76 86.06 89.81 102.07 106.09 98.01 94.74 87.32 85.95 94.60 95.26 97.82 95.57 91.21
Operating Income 215 357 433 458 404 309 175 99 71 -11 -31 11 31 88 104 38 33 14 29 58
Change (%) 66.26 21.24 5.86 -11.71 -23.51 -43.44 -43.24 -28.58 -116.04 172.84 -136.05 176.38 184.03 18.45 -63.27 -14.34 -55.83 103.71 97.57
% of Revenue 20.95 33.04 34.49 35.89 34.53 30.37 21.24 13.94 10.19 -2.07 -6.09 1.99 5.26 12.68 14.05 5.40 4.74 2.18 4.43 8.79
Interest Expense -6 -7 -7 -8 -9 -7 -7 -7 -6 -7 -8 -7 -6 -5 -4 -5 -4 -4 -3 -3
Change (%) 14.55 -3.67 14.26 17.35 -24.13 2.72 -4.69 -9.56 19.34 8.87 -12.96 -9.22 -13.04 -19.12 10.72 -8.06 -14.54 -18.53 -12.59
% of Revenue -0.58 -0.63 -0.53 -0.59 -0.76 -0.66 -0.84 -0.92 -0.85 -1.29 -1.52 -1.20 -1.04 -0.77 -0.58 -0.67 -0.63 -0.56 -0.46 -0.40
Net Income 181 141 168 35 -13 50 -6 15 -6 -398 -416 -374 -366 7 25 -151 -152 -159 -132 48
Change (%) -21.86 19.24 -79.31 -136.17 -494.96 -112.15 -351.61 -142.56 6,049.24 4.32 -9.93 -2.30 -101.97 253.03 -693.21 0.99 4.82 -16.91 -136.55
% of Revenue 17.65 13.08 13.43 2.73 -1.08 4.89 -0.73 2.14 -0.93 -72.64 -81.57 -66.62 -62.14 1.04 3.43 -21.28 -21.99 -24.07 -19.91 7.31

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista